B细胞c1galt1敲除小鼠中Gd-IgA1高表达但无肾小球IgA1沉积
该研究在表达人IgA1重链的小鼠中B细胞特异性敲除c1galt1,观察到循环Gd-IgA1显著升高,但肾小球IgA沉积有限且炎症刺激后未明显增强;而IgAN患者黏膜来源IgA1较血清或骨髓瘤来源IgA1诱导更强系膜沉积,提示Gd-IgA1是黏膜免疫激活标志而非直接致病驱动因素。
要点
- B细胞c1galt1敲除升高循环Gd-IgA1,但肾小球IgA沉积仍有限。
- 炎症刺激未显著增强c1galt1敲除小鼠肾小球IgA沉积。
- IgAN患者黏膜来源IgA1较血清或骨髓瘤来源IgA1系膜沉积更强。
核心结论
- Gd-IgA1是黏膜免疫激活的相关标志而非直接致病驱动因素。
- 组织来源和免疫环境可能是IgA1沉积及致病潜力的关键决定因素。
研究设计与样本
- 在IGHA1敲入表达人IgA1重链的小鼠模型中引入B细胞特异性c1galt1缺失。
- 检测循环Gd-IgA1水平,并在生理条件及炎症刺激下评估肾脏表型。
- 采用被动小鼠模型比较人血清、回盲部黏液及骨髓瘤来源IgA1的肾小球沉积潜力。
主要发现
- B细胞特异性c1galt1缺失在生理及炎症刺激下均显著升高循环Gd-IgA1水平。
- c1galt1缺失小鼠出现B细胞发育受损及全身循环和肠黏膜IgA产生减少。
- c1galt1缺失小鼠肾小球IgA沉积在生理条件下有限,炎症刺激后未明显增强。
- IgAN患者黏膜来源IgA1较血清或骨髓瘤来源IgA1诱导显著更强的系膜沉积,尽管Gd-IgA1含量相似或更低。
临床怎么用
- 评估IgA肾病致病机制时需关注IgA1组织来源与免疫环境,而非仅看Gd-IgA1水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Aberrant O-linked glycosylation of the IgA hinge segment resulting in galactose-deficient IgA1 (Gd-IgA1) is frequently observed in patients with IgA nephropathy (IgAN), and it is hypothesized to be pathogenic. Here, we genetically disrupted the expression of galactosyltransferase 1 (C1galt1) to elevate Gd-IgA1 levels in mice and examine its role in glomerular deposition. METHODS: We previously established a mouse model expressing the human IgA1 heavy chain via an IGHA1-knock-in allele. To investigate the role of aberrant glycosylation, we introduced a B cell-specific deletion of c1galt1 into this model. Circulating Gd-IgA1 levels were measured, and kidney phenotypes were evaluated under physiological conditions and following inflammatory stimulation. Furthermore, using a passive mouse model, we compared the glomerular deposition potential of IgA1 derived from various human sources, including serum, ileocecal mucus, as well as from patients with myeloma. RESULTS: B cell-specific deletion of c1galt1 resulted in markedly elevated circulating Gd-IgA1 levels under both physiological conditions and inflammatory stimulation (Lactobacillus casei cell wall extract and complete Freund's adjuvant), and these mice exhibited impaired B cell development and reduced IgA production in both systemic circulation and intestinal mucosa. Correspondingly, glomerular IgA deposition remained limited under physiological conditions and was not substantially enhanced following inflammatory stimulation. In contrast, mucosa-derived IgA1 from patients with IgAN induced significantly stronger mesangial deposition than serum- or myeloma-derived IgA1, despite having a similar or lower Gd-IgA1 content. CONCLUSIONS: Our findings support Gd-IgA1 as a correlate of mucosal immune activation rather than a direct pathogenic driver. Instead, tissue origin and immune context are likely key determinants of IgA1 deposition and pathogenic potential.
引用
- Wu J, Xie T, Zhang Z, et al. Absence of glomerular IgA1 deposition despite overexpression of galactose-deficient IgA1 in the B cell c1galt1 knockout mouse. Kidney Int. 2026. PMID: 41905596. doi:10.1016/j.kint.2026.02.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。